COSM COSMOS HEALTH INC Expansion Plans 8-K Filing 2025 - Patent License Agreement Cosmos Health Inc has entered into a Patent and Technology License Agreement with DocPharma Single SA, granting them exclusive rights to commercialize two cancer treatment patents for a total potential cost of EUR 7,500,000, with initial and ongoing royalty payments outlined.Get access to all SEC 8-K filings of the COSMOS HEALTH INC